← Back to Screener
USANA Health Sciences Inc (USNA)
Price$18.03
Value ScoreB
Growth ScoreD
Momentum ScoreC
Favorite Metrics
Price vs S&P 500 (26W)-17.09%
Price vs S&P 500 (4W)-4.90%
VGM Score45.66
Market Capitalization$322.36M
P/E Ratio (Annual)29.96x
All Metrics
P/CF (Annual)14.42x
Book Value / Share (Quarterly)$29.45
P/TBV (Annual)0.87x
Revenue Growth (3Y)-2.51%
Cash Flow / Share (Quarterly)$0.16
Price vs S&P 500 (YTD)-16.31%
Gross Margin (TTM)77.55%
Net Profit Margin (TTM)0.96%
EPS (TTM)$0.48
10-Day Avg Trading Volume0.11M
EPS Excl Extra (TTM)$0.48
Revenue Growth (5Y)-4.00%
EPS (Annual)$0.58
ROI (Annual)1.97%
Gross Margin (Annual)78.29%
Net Profit Margin (5Y Avg)5.96%
Cash / Share (Quarterly)$8.82
P/E Basic Excl Extra (TTM)36.33x
Revenue Growth QoQ (YoY)0.27%
EPS Growth (5Y)-37.04%
P/E Normalized (Annual)29.96x
ROA (Last FY)1.45%
Revenue Growth TTM (YoY)5.67%
EBITD / Share (TTM)$3.71
ROE (5Y Avg)13.64%
Operating Margin (TTM)3.85%
Cash Flow / Share (Annual)$0.47
P/B Ratio0.59x
P/B Ratio (Quarterly)0.59x
Net Income / Employee (Annual)$6,900
EV / Revenue (TTM)0.19x
Net Interest Coverage (TTM)103.00x
ROA (TTM)1.21%
EPS Growth QoQ (YoY)-17.13%
EV / EBITDA (TTM)2.55x
EPS Incl Extra (Annual)$0.58
Current Ratio (Annual)2.24x
Quick Ratio (Quarterly)1.47x
3-Month Avg Trading Volume0.13M
52-Week Price Return-37.98%
EV / Free Cash Flow (Annual)20.36x
P/E Incl Extra (TTM)36.33x
Revenue / Employee (TTM)$589,800
Tangible BV / Share (Quarterly)$22.47
P/S Ratio (Annual)0.35x
Asset Turnover (Annual)1.25x
52-Week High$38.32
Operating Margin (5Y Avg)9.41%
EPS Excl Extra (Annual)$0.58
CapEx CAGR (5Y)-1.75%
Tangible BV CAGR (5Y)-0.54%
26-Week Price Return-9.17%
Quick Ratio (Annual)1.35x
13-Week Price Return-0.93%
Total Debt / Equity (Annual)0.03x
Current Ratio (Quarterly)2.51x
Enterprise Value$173.61M
Revenue / Share Growth (5Y)-1.33%
Asset Turnover (TTM)1.26x
Book Value / Share Growth (5Y)6.75%
Revenue / Employee (Annual)$589,300
Inventory Turnover (Annual)2.46x
Pretax Margin (Annual)4.49%
Cash / Share (Annual)$8.66
3-Month Return Std Dev42.49%
Gross Margin (5Y Avg)80.49%
Net Income / Employee (TTM)$5,700
EBITDA CAGR (5Y)-18.12%
EBITDA Interim CAGR (5Y)-14.11%
ROE (Last FY)2.02%
Net Interest Coverage (Annual)50.22x
EPS Basic Excl Extra (Annual)$0.58
P/FCF (TTM)22.54x
Receivables Turnover (TTM)248.40x
EV / Free Cash Flow (TTM)58.63x
Total Debt / Equity (Quarterly)0.03x
EPS Incl Extra (TTM)$0.48
Receivables Turnover (Annual)326.57x
ROI (TTM)1.64%
P/S Ratio (TTM)0.35x
Pretax Margin (5Y Avg)9.96%
Revenue / Share (Annual)$49.81
Tangible BV / Share (Annual)$21.88
Forward P/E8.47x
Free OCF CAGR (5Y)-43.29%
Price vs S&P 500 (52W)-62.34%
P/E Ratio (TTM)36.33x
EPS Growth TTM (YoY)-73.96%
Year-to-Date Return-8.15%
5-Day Price Return-1.64%
EPS Normalized (Annual)$0.58
ROA (5Y Avg)9.79%
Net Profit Margin (Annual)1.16%
Month-to-Date Return-1.48%
Cash Flow / Share (TTM)$3.77
EBITD / Share (Annual)$3.77
EPS Growth (3Y)-45.59%
Operating Margin (Annual)4.05%
LT Debt / Equity (Annual)0.09x
P/CF (TTM)19.39x
ROI (5Y Avg)13.56%
P/E Excl Extra (TTM)36.33x
LT Debt / Equity (Quarterly)0.27x
EPS Basic Excl Extra (TTM)$0.48
P/TBV (Quarterly)0.78x
P/B Ratio (Annual)0.65x
Inventory Turnover (TTM)2.45x
Pretax Margin (TTM)4.35%
Book Value / Share (Annual)$29.16
Price vs S&P 500 (13W)-9.19%
Net Margin Growth (5Y)-36.22%
Beta0.77x
P/FCF (Annual)37.81x
Revenue / Share (TTM)$50.29
ROE (TTM)1.66%
52-Week Low$16.60
vGradeB
gGradeD
mGradeC
vgmGradeC
Show chart for
Earnings Surprise History
Q1 260.61est. 0.45
Analyst Recommendations
Mar 2025
Apr 2025
May 2025
Jun 2025
2.17
2.17
2.17
2.17
Industry Peers — Pharmaceutical Preparations(17)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
USNAUSANA Health Sciences Inc | B | D | C | $18.03 |
| DFTXDefinium Therapeutics, Inc. Common Shares | — | — | A | $23.55 |
| CRONCronos Group Inc. Common Share | C | B | B | $2.74 |
| TLRYTilray Brands, Inc. Common Stock | B | B | D | $4.94 |
| CGCCanopy Growth Corporation Common Shares | C | D | C | $1.03 |
| NAGENiagen Bioscience, Inc. Common Stock | C | B | D | $3.45 |
| SNDLSundial Growers Inc. Common Shares | A | C | C | $1.42 |
| ACBAurora Cannabis Inc. Common Shares | B | C | C | $3.38 |
| MDWDMediWound Ltd. | D | F | D | $14.18 |
| FTLFFitLife Brands, Inc. Common Stock | B | C | D | $9.87 |
| BTMDBiote Corp. Class A Common Stock | B | D | C | $2.34 |
About
USANA Health Sciences Inc develops and manufactures science-based nutritional, personal care, and skincare products focused on long-term health and wellness. The company operates through two segments: direct selling, which generates the majority of revenue across multiple geographic markets, and Hiya, a direct-to-consumer children's health brand in the U.S. These dual channels allow USANA to reach both adult and pediatric wellness markets globally.